Anticancer agent 176
Anticancer agent 176 (Compoint 10α) is an anticancer agent. Anticancer agent 176 exhibits excellent in vitro cytotoxic activity against neuroblastoma with an IC50 value of 6.3 μM[1].
Product Specifications
CAS Number
[9007-83-4]
UNSPSC
12352005
Target
Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-176.html
Solubility
10 mM in DMSO
Smiles
C[C@H](C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)O[C@H]2O[C@@H]3CO[C@H](O[C@H]3[C@@H]([C@H]2OCC4=CC=C(C=C4)F)N)C5=CC=CC=C5
Molecular Formula
C30H28F7NO5
Molecular Weight
615.54
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163089/Anticancer-agent-176-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163089/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Tfap2a (Transcription Factor AP-2-alpha, AP2-alpha, AP-2 Transcription Factor, Activating Enhancer-Binding Protein 2-alpha, Activator Protein 2, AP-2, Tfap2a, Ap2tf, Tcfap2a) (HRP)
Tfap2a (Transcription Factor AP-2-alpha, AP2-alpha, AP-2 Transcription Factor, Activating Enhancer-Binding Protein 2-alpha, Activator Protein 2, AP-2, Tfap2a, Ap2tf, Tcfap2a) (HRP)
Lentiviral mouse Tex13b shRNA (UAS) - Lentiviral mouse Tex13b shRNA (UAS, GFP) plasmid
